Elizabeth Bryda

Dr. Elizabeth Bryda

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

19 September 2016 in Scientific Reports
Verified
Journal Article
Open access
PDF file
DDDaniel J. Davis
Daniel J. Davis
HDHolly M. Doerr
Holly M. Doerr
AGAgata K. Grzelak
Agata K. Grzelak
SBSusheel Bhanu Busi
Susheel Bhanu Busi
EJEldin Jasarevic
Eldin Jasarevic
EBElizabeth Bryda
Elizabeth Bryda
The consumption of probiotics has become increasingly popular as a means to try to improve health and well-being. Not only are probiotics considered beneficial to digestive health, but increasing evidence suggests direct and indirect interactions between gut microbiota (GM) and the central nervous system (CNS). Here, adult zebrafish were supplemented with Lactobacillus plantarum to determine the effects of probiotic treatment on structural and functional changes of the GM, as well as host neurological and behavioral changes. L. plantarum administration altered the β-diversity of the GM while leaving the major core architecture intact. These minor structural changes were accompanied by significant enrichment of several predicted metabolic pathways. In addition to GM modifications, L. plantarum treatment also significantly reduced anxiety-related behavior and altered GABAergic and serotonergic signaling in the brain. Lastly, L. plantarum supplementation provided protection against stress-induced dysbiosis of the GM. These results underscore the influence commensal microbes have on physiological function in the host and demonstrate bidirectional communication between the GM and the host.

10 September 2015 in Oncotarget
Verified
Journal Article
Open access
PDF file
AEAaron C. Ericsson
Aaron C. Ericsson
SASadia Akter
Sadia Akter
MHMarina M. Hanson
Marina M. Hanson
SBSusheel Bhanu Busi
Susheel Bhanu Busi
Taybor ParkerTaybor Parker
Taybor Parker
EBElizabeth Bryda
Elizabeth Bryda
Differential susceptibility to colorectal cancer due to naturally occurring gut microbiota

28 March 2012 in Stem Cells and Development
Verified
Journal Article
Open access
HMHongsheng Men
Hongsheng Men
BBBeth A. Bauer
Beth A. Bauer
EBElizabeth Bryda
Elizabeth Bryda
Germline-competent rat embryonic stem (ES) cell lines are important resources for the creation of mutant rat models using ES-cell-based gene targeting technology. The ability to isolate germline-competent ES cell lines from any rat strain, including genetically modified strains, would allow for more sophisticated genetic manipulations without extensive breeding. Sprague Dawley (SD) males carrying an enhanced green fluorescent protein (EGFP) transgene were used as the founder animals for the derivation of ES cell lines. A number of ES cell lines were established and subjected to rigorous quality control testing that included assessment of pluripotency factor expression, karyotype analysis, and pathogen/sterility testing. Two male ES cell lines, SD-Tg.EC1/Rrrc and SD-Tg.EC8/Rrrc, were injected into blastocysts recovered from a cross of Dark Agouti (DA) males with SD females. Resulting chimeric animals were bred with wild-type SD mates to verify the germline transmissibility of the ES cell lines by identifying pups carrying the ES cell line–derived EGFP transgene. While both ES cell lines gave rise to chimeric animals, only SD-Tg.EC1 was germline competent. This confirms the feasibility of deriving germline-competent ES cell lines from transgenic rat strains and provides a novel ES cell line with a stable green fluorescent protein (GFP) reporter for future genetic manipulations to create new rat models.

1 April 2010
Verified
Journal Article
Closed access
DBDenise J Bouvrette
Denise J Bouvrette
VSVinoth Sittaramane
Vinoth Sittaramane
JHJerry R Heidel
Jerry R Heidel
ACAnand Chandrasekhar
Anand Chandrasekhar
EBElizabeth Bryda
Elizabeth Bryda

2 November 2021 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
CSCaley E Smith
Caley E Smith
MLMonique A Lorson
Monique A Lorson
SHSara M Ricardez Hernandez
Sara M Ricardez Hernandez
ZRZayd Al Rawi
Zayd Al Rawi
JMJiude Mao
Jiude Mao
Christian LorsonChristian Lorson
Christian Lorson
Spinal muscular atrophy with respiratory distress type I (SMARD1) is a neurodegenerative disease defined by respiratory distress, muscle atrophy and sensory and autonomic nervous system defects. SMARD1 is a result of mutations within the IGHMBP2 gene. We have generated six Ighmbp2 mouse models based on patient-derived mutations that result in SMARD1 and/or Charcot-Marie Tooth Type 2 (CMT2S). Here we describe the characterization of one of these models, Ighmbp2D564N (human D565N). The Ighmbp2D564N/D564N mouse model mimics important aspects of the SMARD1 disease phenotype, including motor neuron degeneration and muscle atrophy. Ighmbp2D564N/D564N is the first SMARD1 mouse model to demonstrate respiratory defects based on quantified plethysmography analyses. SMARD1 disease phenotypes, including the respiratory defects, are significantly diminished by intracerebroventricular (ICV) injection of ssAAV9-IGHMBP2 and the extent of phenotypic restoration is dose-dependent. Collectively, this model provides important biological insight into SMARD1 disease development.